ES8801583A1 - Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus. - Google Patents

Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.

Info

Publication number
ES8801583A1
ES8801583A1 ES550089A ES550089A ES8801583A1 ES 8801583 A1 ES8801583 A1 ES 8801583A1 ES 550089 A ES550089 A ES 550089A ES 550089 A ES550089 A ES 550089A ES 8801583 A1 ES8801583 A1 ES 8801583A1
Authority
ES
Spain
Prior art keywords
oil
manufacturing process
preparation
vaccines
adjuvated vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550089A
Other languages
English (en)
Spanish (es)
Other versions
ES550089A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES8801583A1 publication Critical patent/ES8801583A1/es
Publication of ES550089A0 publication Critical patent/ES550089A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES550089A 1984-12-20 1985-12-18 Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus. Expired ES8801583A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843446515 DE3446515A1 (de) 1984-12-20 1984-12-20 Oeladjuvierte vaccine und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES8801583A1 true ES8801583A1 (es) 1988-02-16
ES550089A0 ES550089A0 (es) 1988-02-16

Family

ID=6253325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550089A Expired ES8801583A1 (es) 1984-12-20 1985-12-18 Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.

Country Status (8)

Country Link
EP (1) EP0187286A1 (forum.php)
DE (1) DE3446515A1 (forum.php)
DK (1) DK593985A (forum.php)
ES (1) ES8801583A1 (forum.php)
FI (1) FI855057A7 (forum.php)
GR (1) GR853058B (forum.php)
NO (1) NO855169L (forum.php)
PT (1) PT81713B (forum.php)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DE3817531A1 (de) * 1988-05-24 1989-12-07 Behringwerke Ag Antigenloesung enthaltend ein polyalphaolefin (pao), verfahren ihrer herstellung und die verwendung von pao als adjuvans
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
EP2050465B1 (en) * 1997-08-29 2014-06-11 Antigenics Inc. Compositions comprising the adjuvant QS-21 and polysorbate or cyclodextrin as excipient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL269002A (forum.php) * 1960-09-06
GB1083815A (en) * 1963-10-01 1967-09-20 Wellcome Found Vaccine adjuvants
GB1035701A (en) * 1964-03-03 1966-07-13 Merck & Co Inc Emulsions suitable for use as adjuvants for immunological agents
GB1128325A (en) * 1964-11-11 1968-09-25 Wellcome Found Improvements in water-in-oil emulsion vaccines
GB1081796A (en) * 1965-08-13 1967-08-31 Wright Fleming Inst Of Microbi Improvements in or relating to oily adjuvants for water-in-oil emulsions of antigenic materials
EP0059521B1 (en) * 1981-03-03 1985-01-02 Centraal Diergeneeskundig Instituut Water-in-oil emulsion for use in the potentation of the immune system of animals
DE3308458A1 (de) * 1983-03-10 1984-09-13 Behringwerke Ag, 3550 Marburg Verfahren zur adjuvierung von vaccinen

Also Published As

Publication number Publication date
EP0187286A1 (de) 1986-07-16
DK593985D0 (da) 1985-12-19
PT81713B (de) 1987-08-10
NO855169L (no) 1986-06-23
ES550089A0 (es) 1988-02-16
GR853058B (forum.php) 1986-04-15
FI855057L (fi) 1986-06-21
DE3446515A1 (de) 1986-06-26
DK593985A (da) 1986-06-21
FI855057A7 (fi) 1986-06-21
PT81713A (de) 1986-01-01
FI855057A0 (fi) 1985-12-18

Similar Documents

Publication Publication Date Title
SE8205144L (sv) Hydrofob kiseldioxid eller silikat, medel som innehaller dessa och metoder for tillverkning och anvendning derav
AU7480787A (en) Composition to encapsulate toxic metal and/or organic pollutants from wastes
ES2174520T3 (es) Preparacion de zeolita aglutinada por una zeolieta de tipo de estructura mfi y su uso..
AR015013A1 (es) Metodo mejorado para eliminar la espuma de fermentaciones alcoholicas y composicion desespumante aplicable en dicho metodo.
BR8504398A (pt) Sistema de radiocomunicacao,transceptor remoto,processos para enviar mensagens para estacao central/estacao terrestre a partir de um transceptor remoto;processo para enviar mensagens para transceptor remoto a partir de uma estacao central e processo para enviar mensagens de transceptor de envio para transceptor de destino
KR840004040A (ko) 수경성 시멘트 조성물
BR9307700A (pt) Formulação para estabilizar uma composição enzimática lìquida, composição enzimática lìquida estabilizada, método para a preparação de uma composição enzimática lìquida estabilizada e método para estabilizar uma composição enzimática lìquida
NO933923L (no) Lavfluidtapssementsammensetninger, fluidtapsreduserende tilsetningsstoffer og metoder
MX169950B (es) Gel de silice y alumina cataliticamente activo y procedimiento para su preparacion
BR0009485A (pt) Método e composições para evitar ou reduzir infecção por hiv pelo uso de inibidores para leucina aminopeptidase
ES528619A0 (es) Procedimiento para la preparacion de 4-amino-metileno-cromanos y -cromenos sustituidos
BR8405020A (pt) Processo para preparacao de derivados de ciclo-hexenol,e,composicoes herbicidas,contendo tais derivados
IE870663L (en) Phosolipid-containing products
ES8801583A1 (es) Procedimiento para producir una vacuna coadyuvada que contiene un antigeno seleccionado de proteinas, bacterias y virus.
ES8608216A1 (es) Un procedimiento para encapsular en cemento una suspension.
DE3585803D1 (de) Fluessige puffersysteme.
ES8603351A1 (es) Un metodo para someter a tratamiento un sistema acuoso susceptible de ser sujeto a contaminacion biologica
ES8506548A1 (es) Un metodo de formacion de un producto de vidrio o ceramica
ES2004240A6 (es) Una composicion de coenzima estabilizada
AR011447A1 (es) Procedimiento para preparar un derivado de tiazolidindiona substituido y compuesto intermediario
PT81970B (pt) Processo para a preparacao de um reagente para a dosagem, por hemaglutinacao, de anticorpos contra as toxinas bacterianas
ES8106284A1 (es) Un procedimiento para la preparacion de precursores de alil sulfoxidos inhibidores de enzinas.
DE59204439D1 (de) Verfahren für das paralysieren von schwermetallen im boden.
SE8404334L (sv) 16-fluoro-16,17-didehydro-prostanoider och forfarande for deras framstellning
FI833451A7 (fi) Kudosviljelmä ja solun kasvua edistävä aines sekä sen valmistusmenetelmä.